asprey glutathione blog After 25 years of using Glutathione, why did Dave make the switch?, In this episode, Dave shares why he transitioned to our topical Glutaryl, and the results he’s seen. , Dr Patel also dives Answering Dave Asprey's TOP HBOT

Two predicted drugs (gemcitabine and cladribine) and one NO-based drug (diphenyleneiodonium) have a reported median IC 50 below 0.4 M in melanoma cell lines, this being comparable to known anti-melanoma drugs (Supplementary Fig

Each dataset was carefully assessed for potential aggregation and adsorption artifacts by evaluating MST traces and capillary scans, respectively

Proceedings of the National Academy of Sciences of the United States of America, 108 (52), 2106921074

Mutations in the MTHFR gene can result in lower levels of or less functional MTHFR enzyme

Material is intended for use by qualified researchers in controlled laboratory environments only